Caregivers
There is an increased risk of cancer in A-T carriers necessitating enhanced cancer surveillance.
A-T organizations around the world collaborate and look for a cure.
Physicians may consult a hematologist who is familiar with cancer and A-T.
Children with A-T, just as all children, have variability in their cognitive abilities.
Speech and language abilities vary from one person with A-T to another, and vary over time in individual patients.
A-T symptoms can create difficulty for completing reading and writing tasks.
Children and adults with A-T are at increased risk for respiratory problems.
A-T signs and symptoms are distinctive yet vary widely in severity from person to person.
The gene causing A-T (the ATM gene) was identified in 1995. This gene produces ATM protein.
A-T is inherited, or passed on, in families from parents to children.